Hyperprogressive Disease in Malignant Carcinoma With Immune Checkpoint Inhibitor Use: A Review
Immune checkpoint inhibitors (ICIs) have shown durable remissions and improved long-term survival across a variety of cancer types. However, there is growing evidence that a significant subset of nonresponsive patients may exhibit hyperprogressive disease (HPD) during the initiation of immune checkp...
Na minha lista:
| Principais autores: | , |
|---|---|
| Formato: | Artigo |
| Idioma: | Inglês |
| Publicado em: |
Frontiers Media S.A.
2022-03-01
|
| coleção: | Frontiers in Nutrition |
| Assuntos: | |
| Acesso em linha: | https://www.frontiersin.org/articles/10.3389/fnut.2022.810472/full |
| Tags: |
Sem tags, seja o primeiro a adicionar uma tag!
|